Biogen

Biogen, founded in 1978, is a global biotechnology leader that translates cutting-edge science into transformative medicines for patients worldwide. Leveraging deep insights into human biology and a portfolio of diverse modalities, the company focuses on first-in-class therapies that deliver superior clinical outcomes. Biogen balances bold scientific risk with disciplined return on investment to drive sustainable long-term growth and create value for shareholders and communities. With headquarters in Cambridge, Massachusetts and international operations spanning 30 countries, the company supports a worldwide reach through its own affiliates and a broad distribution network.